Why RNAi makes sense

被引：30

作者：

Hough, SR ^{[1
]}

Wiederholt, KA ^{[1
]}

Burrier, AC ^{[1
]}

Woolf, TM ^{[1
]}

Taylor, MF ^{[1
]}

机构：

[1] Sequitur Inc, Natick, MA 01760 USA

来源：

NATURE BIOTECHNOLOGY | 2003年 / 21卷 / 07期

关键词：

D O I：

10.1038/nbt0703-731b

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：731 / 732

页数：3

共 11 条

[1] Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes [J].

Amarzguioui, M ;

Brede, G ;

Babaie, E ;

Grotli, M ;

Sproat, B ;

Prydz, H .

NUCLEIC ACIDS RESEARCH, 2000, 28 (21) :4113-4124

[2] Tolerance for mutations and chemical modifications in a siRNA [J].

Amarzguioui, M ;

Holen, T ;

Babaie, E ;

Prydz, H .

NUCLEIC ACIDS RESEARCH, 2003, 31 (02) :589-595

[3] Efficiency of antisense oligonucleotide drug discovery [J].

Bennett, CF .

ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2002, 12 (03) :215-224

[4] Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems [J].

Caplen, NJ ;

Parrish, S ;

Imani, F ;

Fire, A ;

Morgan, RA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) :9742-9747

[5] A microRNA in a multiple-turnover RNAi enzyme complex [J].

Hutvágner, G ;

Zamore, PD .

SCIENCE, 2002, 297 (5589) :2056-2060

[6] Elucidating cell signaling mechanisms using antisense technology [J].

Koller, E ;

Gaarde, WA ;

Monia, BP .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (04) :142-148

[7]

KRIEG PA, 1987, METHOD ENZYMOL, V155, P397

[8] Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents - A comparative analysis [J].

Vickers, TA ;

Koo, S ;

Bennett, CF ;

Crooke, ST ;

Dean, NM ;

Baker, BF .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :7108-7118

[9]

WOOLF TM, 1998, Patent No. 9819492

[10]

WOOLF TM, 1998, Patent No. 981949

← 1 2 →